Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intraperitoneal distribution imaging in ovarian cancer patients.
Dawson SJ, Hicks RJ, Johnston V, Allen D, Jobling T, Quinn M, Rischin D. Dawson SJ, et al. Among authors: rischin d. Intern Med J. 2011 Feb;41(2):167-71. doi: 10.1111/j.1445-5994.2009.02112.x. Intern Med J. 2011. PMID: 19849742 Clinical Trial.
Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancer.
Prince HM, Gardyn J, Millward MJ, Rischin D, Francis P, Gates P, Chapple P, Quinn M, Juneja S, Wolf M, Januszewicz EH, Richardson G, Scarlett J, Briggs P, Brettell M, Toner GC. Prince HM, et al. Among authors: rischin d. Bone Marrow Transplant. 1999 Mar;23(5):427-35. doi: 10.1038/sj.bmt.1701606. Bone Marrow Transplant. 1999. PMID: 10100555 Clinical Trial.
Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study.
Prince HM, Millward MJ, Rischin D, Blakey D, Francis P, Gates P, Chapple P, Quinn M, Juneja S, Wolf M, Januszewicz EH, Seymour JF, Brettell M, Strickland A, Zalcberg J, Richardson G, Scarlett J, Briggs P, Toner GC. Prince HM, et al. Among authors: rischin d. Ann Oncol. 1999 Apr;10(4):479-81. doi: 10.1023/a:1008317205955. Ann Oncol. 1999. PMID: 10370794 Free article. Clinical Trial.
Docetaxel effectively mobilizes peripheral blood CD34+ cells.
Prince HM, Toner GC, Seymour JF, Blakey D, Gates P, Eerhard S, Chapple P, Wall D, Quinn M, Juneja S, Wolf M, Januszewicz EH, Richardson G, Scarlett J, Briggs P, Brettell M, Rischin D. Prince HM, et al. Among authors: rischin d. Bone Marrow Transplant. 2000 Sep;26(5):483-7. doi: 10.1038/sj.bmt.1702540. Bone Marrow Transplant. 2000. PMID: 11019836
Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study.
Prince HM, Rischin D, Toner GC, Seymour JF, Blakey D, Gates P, Eerhard S, Chapple P, Quinn M, Brettell M, Juneja S, Wolf M, Januszewicz EH, Richardson G, Scarlett J, Briggs P. Prince HM, et al. Among authors: rischin d. Bone Marrow Transplant. 2000 Nov;26(9):955-61. doi: 10.1038/sj.bmt.1702650. Bone Marrow Transplant. 2000. PMID: 11100274 Clinical Trial.
F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment.
Mac Manus MP, Hicks RJ, Ball DL, Kalff V, Matthews JP, Salminen E, Khaw P, Wirth A, Rischin D, McKenzie A. Mac Manus MP, et al. Among authors: rischin d. Cancer. 2001 Aug 15;92(4):886-95. doi: 10.1002/1097-0142(20010815)92:4<886::aid-cncr1397>3.0.co;2-v. Cancer. 2001. PMID: 11550162
306 results